Skip to main content
. 2018 Apr 4;16:87. doi: 10.1186/s12967-018-1458-y

Fig. 2.

Fig. 2

Disease-free survival (DFS) was significantly longer in patients with low, compared to high, PD-1 and PD-L1 expressions (p = 0.006, log-rank) (a) (p = 0.001, log-rank) (b). DFS did not differ significantly between patients with low vs high PD-L2 expression (p = 0.657, log-rank) (c)